Although MX25-1 also induced degradation of MDM2 oncoprotein in MYCN-amplified NB, the MDM2-p53 pathway appears dispensable for the cytotoxic activity of MX25-1 in this type of cancer. Here, MYCN is linked to neuroblastoma.